References
- ADAMCZYK, M., FISHPAUGH, J. R. and JOHNSON, D., 1992, Effi cient synthesis of tricyclic antidepressant normetabolites. OPPI Briefs, 24, 168–171.
- BRADEN, N. J., JACKSON, J. E. and WALSON, P. D .,1986, Tricyclic antidepressantoverdose. The Perliatrk Clinics of North America, 33, 287–297.
- FASOLI, R. A. and GLAUSER, F. L., 1981, Cardiac arrhythmias and ECG abnormalities in tricyclic antidepressant overdose. Clinical Toxicology, 18, 155–163.
- FAULKNER, R. D., PITTS, W. M., LEE, C. S., LEWIS, W. A. and FANN, W. E., 1983, Multiple-dose doxepin kinetics in depressed patients. Clinical Pharmacology and Therapeutics, 34, 509–515.
- GHABRIAL, H., PRAKASH, C., TACKE, U. G., BLAIR, I. A. and WILKINSON, G. R., 1991, Geometric isomerizationof doxepin during its N-demethylationin humans.Drug Metabolism and Disposition, 19, 596–599.
- GREEN, D. O., 1978, Clinical importance of doxepin antidepressant plasma levels. journal of Clinical Psychiatry, 39, 481–482.
- HRDINA, P. D., BAKISH, D., SWENSON, S. and LAP1ERRE, Y. D., 1990, Cis- and trans-isomers of doxepin and desmethyldoxeph in the plasma of depressed patients treated with doxepin. Therapy and Drug Monitoring, 12,129–133.
- LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
- LUO, H., HAWES, E. M., MuKAY, G., KORCHINSKI, E. D. and MIDHA, K. K., 1991, The quaternary ammonium-linked glucuronideof doxepin: a majormetabolite in depressed patients treated with doxepin. Drug Metabolism and Disposition, 19, 722–724.
- MIDHA, K. K., HUBBARD, J. W., MCKAY, G., HAWES, E. M., KORCHINSKI, E. D., GURNSEY, T., COOPER, J. K. and SCHWEDE, R., 1992, Stereoselective pharm acokinetics of doxepin isomers. European Journal of Clinical Pharmacology, 42, 539–544.
- PELLINEN, T. J., FARKKILA, M., HEIKKILA, J. and LUOMANMAKI, K., 1987, Electrocardiographic and clinical features of tricyclic antidepressant intoxication. Annals of Clinical Research, 19, 12–17.
- PENTEL, P. R. and BENOWITZ, N. L., 1986, Tricyclic antidepressant poisoning. Management of arrhythmias. Medkal Toxicology, 1, 101–121.
- PINDER, R. M., BROGDEN, R. N., SPEIGHT, T. M. and AVERY, G. S., 1977, Doxepinup-to-date: a review of its pharmacologicalproperties and therapeutic eft cacy with particular reference to depression. Drugs, 13, 161–218.
- ROSSEEL, M. T., BOGAERT, M. G. and CLAEVS, M., 1978, Quantitative GLC determination of cis- and trans-isomers of doxepin and desmethyldoxepiu journal of Pharmaceutical Science, 67, 802–805.
- SHU, Y. Z., HUBBARD, j. W., COOPER, J. K.,MuKAY, G., KORCHINSKI, E. D., KUMAR, R. and MIDHA, K. K., 1990a, The identification of urinary metabolites of doxepin in patients. Drug Metabolism and Disposition, 18, 735–741.
- SHU, Y. Z., HUBBARD, J. W., MCKAY, G. and MIDHA, K. K., 1990b, Identification of phenolic doxepin glucuronides from patient urine and rat bile. Drug Metabolism and Disposition, 18, 1096–1099.
- WARD, N. G., BLOOM, V. L., WILSON, L., RASKIND, M. and RAISYS, V. A., 1982, D oxepinplasma levels and therapeutic response in depression: preliminary findings. journal of Clinical Psychopharma - cology,, 2, 126–128.
- YAN, J.-H., HUBBARD, J. W., MCKAY, G. and MrooA, K. K., 1997, Stereoselective and simultaneous measurementof cis- and trans -isomers of doxepin and N-desmethyldoxepia in plasma or urine by high-performance liquid chromatography. Journal of Chromatography, B, 691, 131–138.